⌘K

Login Start Free

Home/Filings/4/0001062993-25-000404

4//SEC Filing

Qamar Huma 4

Accession 0001062993-25-000404

CIK 0001372299other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:01 PM ET

Size

5.4 KB

Accession

0001062993-25-000404

Insider Transaction Report

Form 4

Period: 2025-01-02

Ocugen, Inc.OCGN

Chief Medical Officer

Transactions

Award
Option (Right to Buy)
2025-01-02+1,145,468→ 1,145,468 total
Exercise: $0.90Exp: 2035-01-02→ Common Stock (1,145,468 underlying)

Footnotes (1)

[F1]The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Ocugen, Inc.

CIK 0001372299

Entity typeother

Related Parties

1

filerCIK 0002015296

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 5:01 PM ET
Size: 5.4 KB

View on SEC.gov